Page last updated: 2024-08-21

lactulose and Bone Cancer

lactulose has been researched along with Bone Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anthony, DC; Glinskii, OV; Glinsky, GV; Glinsky, VV; Mawhinney, TP; Mossine, VV; Pienta, KJ; Sud, S	1

Other Studies

1 other study(ies) available for lactulose and Bone Cancer

Article	Year
Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine. Neoplasia (New York, N.Y.), 2012, Volume: 14, Issue:1 Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Biomimetic Materials; Bone Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Galectin 3; Humans; Lactulose; Leucine; Male; Mice; Mice, SCID; Prostatic Neoplasms; Xenograft Model Antitumor Assays	2012

Article

Year

Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.

Neoplasia (New York, N.Y.), 2012, Volume: 14, Issue:1

Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Biomimetic Materials; Bone Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Galectin 3; Humans; Lactulose; Leucine; Male; Mice; Mice, SCID; Prostatic Neoplasms; Xenograft Model Antitumor Assays

2012